Article
UPC Aligns With The EPO In Allowing Functional Antibody Claims
While the U.S. Supreme Court rejected Amgen's functionally defined anti-PCSK9 antibody claims based on its high bar for enablement, the European Patent Office ("EPO") found such broad antibody claims allowable.

Jones Day







